# Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach

> **NCT05764720** · NA · RECRUITING · sponsor: **Varian, a Siemens Healthineers Company** · enrollment: 134 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **RADIATION:** Daily Adaptive External Beam Radiation Therapy

## Key facts

- **NCT ID:** NCT05764720
- **Lead sponsor:** Varian, a Siemens Healthineers Company
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-14
- **Primary completion:** 2028-03
- **Final completion:** 2030-03-15
- **Target enrollment:** 134 (ESTIMATED)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05764720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05764720, "Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized Approach". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT05764720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*